We help investors understand market behavior through structured insights on earnings, valuation, and sector trends.
As of 2026-04-09, Replimune Group Inc. (REPL) is trading at $6.16, posting a 4.59% gain on the session amid mixed broader market activity. This analysis, aligned with recent market coverage of REPL, explores key technical levels, recent trading context, and potential near-term scenarios for the clinical-stage biotechnology firm, which focuses on developing oncolytic immunotherapies for cancer treatment. No recent earnings data is available for REPL at the time of writing, so short-term price act
Is Replimune Group (REPL) Stock cyclical or stable | Price at $6.16, Up 4.59% - Passive Flow
REPL - Stock Analysis
4327 Comments
848 Likes
1
Nykole
Trusted Reader
2 hours ago
{协议答案}
👍 197
Reply
2
Baseemah
Active Contributor
5 hours ago
{协议答案}
👍 241
Reply
3
Nezra
Active Reader
1 day ago
{协议答案}
👍 85
Reply
4
Katelynn
Insight Reader
1 day ago
{协议答案}
👍 209
Reply
5
Giuliano
Consistent User
2 days ago
{协议答案}
👍 12
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.